We have located links that may give you full text access.
Diagnostic performance of 64-channel multidetector CT in the evaluation of gastric cancer: differentiation of mucosal cancer (T1a) from submucosal involvement (T1b and T2).
Radiology 2010 June
PURPOSE: To identify the computed tomographic (CT) findings in T1a and T1b cancers and to evaluate the diagnostic performance of multidetector CT with two-dimensional multiplanar reconstruction and three-dimensional CT gastrography for evaluating the preoperative staging of gastric cancer, with special emphasis on the differentiation between T1a and T1b cancers.
MATERIALS AND METHODS: The institutional review board approved this retrospective study. A total of 148 patients with gastric cancer (64 T1a, 36 T1b, and 48 T2) were included. To identify CT findings in T1a and T1b cancers, two radiologists in consensus interpreted the preoperative CT images of the 100 T1 cancers to determine the morphologic characteristics to be used as staging criteria on CT images. By using univariate and multiple logistic regression analyses, the diagnostic criteria to identify T1a and T1b cancers were developed. To evaluate the diagnostic performance of multidetector CT by using the criteria, two other blinded reviewers independently analyzed the CT images of all 148 patients to assess the T (classifying the depth of invasion as T1a, T1b, or T2) and N (classifying nodal involvement as absent or present) stage. CT staging was correlated with histopathologic results. Interobserver agreement was assessed by using weighted kappa statistics.
RESULTS: The detectability of T1b cancer was significantly higher than that of T1a cancer (P = .003). T1b cancer showed well-enhancing mucosal thickening more frequently than did T1a cancer (P = .002). By using the modified CT criteria, the overall accuracy values of T staging and N staging were 64.9% (96/148) and 79.1% (117/148) for reviewer 1 and 63.5% (94/148) and 83.8% (124/148) for reviewer 2, respectively. Weighted kappa values of T and N staging were 0.795 and 0.641, respectively.
CONCLUSION: On multidetector CT images, T1a cancer shows different imaging features than does T1b cancer regarding enhancing characteristics and detectability. Multidetector CT provides relatively valuable results of T and N staging, including differentiation between T1a, T1b, and T2 gastric cancers.
MATERIALS AND METHODS: The institutional review board approved this retrospective study. A total of 148 patients with gastric cancer (64 T1a, 36 T1b, and 48 T2) were included. To identify CT findings in T1a and T1b cancers, two radiologists in consensus interpreted the preoperative CT images of the 100 T1 cancers to determine the morphologic characteristics to be used as staging criteria on CT images. By using univariate and multiple logistic regression analyses, the diagnostic criteria to identify T1a and T1b cancers were developed. To evaluate the diagnostic performance of multidetector CT by using the criteria, two other blinded reviewers independently analyzed the CT images of all 148 patients to assess the T (classifying the depth of invasion as T1a, T1b, or T2) and N (classifying nodal involvement as absent or present) stage. CT staging was correlated with histopathologic results. Interobserver agreement was assessed by using weighted kappa statistics.
RESULTS: The detectability of T1b cancer was significantly higher than that of T1a cancer (P = .003). T1b cancer showed well-enhancing mucosal thickening more frequently than did T1a cancer (P = .002). By using the modified CT criteria, the overall accuracy values of T staging and N staging were 64.9% (96/148) and 79.1% (117/148) for reviewer 1 and 63.5% (94/148) and 83.8% (124/148) for reviewer 2, respectively. Weighted kappa values of T and N staging were 0.795 and 0.641, respectively.
CONCLUSION: On multidetector CT images, T1a cancer shows different imaging features than does T1b cancer regarding enhancing characteristics and detectability. Multidetector CT provides relatively valuable results of T and N staging, including differentiation between T1a, T1b, and T2 gastric cancers.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app